Anti-idiotype responses abrogate anti-CD4–induced tolerance to a tumor-specific antigen and promote systemic tumor immunity

By Kennedy Ronald   Shearer Michael   Lowe Devin   Jumper Cynthia   Chiriva-Internati Maurizio   Bright Robert  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 11, 2004-11 ,pp. : 987-994

Springer Publishing Company

Access to resources Recommend Favorite

CpG-Oligodeoxynucleotides activate tyrosinase-related protein 2–specific T lymphocytes but do not lead to a protective tumor-specific memory response

By Sfondrini Lucia   Besusso Dario   Bronte Vincenzo   Macino Beatrice   Rossini Anna   Colombo Mario   Ménard Sylvie   Balsari Andrea  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 8, 2004-08 ,pp. : 697-704

Springer Publishing Company

Access to resources Recommend Favorite

Synthetic innate defense regulator peptide combination using CpG ODN as a novel adjuvant induces longlasting and balanced immune responses

By                                

Molecular Medicine Reports, Vol. 13, Iss. 1, 2016-01 ,pp. : 915-924

Spandidos Publications

Access to resources Recommend Favorite

Aberrant CpG Island Methylation of Multiple Genes in Ependymal Tumors

By Eva Alonso M.   Josefa Bello M.   Gonzalez-Gomez Pilar   Arjona Dolores   de Campos Jose   Gutierrez Manuel   Rey Juan  

Journal of Neuro-Oncology, Vol. 67, Iss. 1-2, 2004-03 ,pp. : 159-165

Springer Publishing Company

Access to resources Recommend Favorite

Depletion of CD4⁺CD25⁺ Regulatory T Cells Promotes a Tumor-Specific Immune Response in Pancreas Cancer–Bearing Mice

By Viehl Carsten   Moore Todd   Liyanage Udaya   Frey Daniel   Ehlers Jesmin   Eberlein Timothy   Goedegebuure Peter   Linehan David  

Annals of Surgical Oncology, Vol. 13, Iss. 9, 2006-09 ,pp. : 1252-1258

Springer Publishing Company

Access to resources Recommend Favorite